SightfileU.S. market data from official filings

Companies › AVIR

ATEA PHARMACEUTICALS INC (AVIR)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001593899 · EDGAR filings · Updated 2026-06-23

ATEA PHARMACEUTICALS INC (AVIR) has reported institutional ownership of 75.4%, with 127 institutional managers holding positions valued at $322.8M per the latest 13F reporting period.

Institutional ownership
75.4%
Institutional managers
127
Reported 13F value
$322.8M
Insider activity
20 trans.
$0 net flat

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ATEA PHARMACEUTICALS INC has 127 institutional holders and institutional ownership of 75.4%.

Insider activity

Insiders reported 20 transactions (0 buys, 0 sells) across 12 reporting insiders, with a net reported value of $0.

Related companies

ENANTA PHARMACEUTICALS INC (ENTA) · PERSPECTIVE THERAPEUTICS INC (CATX) · OMEROS (OMER) · ENTRADA THERAPEUTICS INC (TRDA) · VANDA PHARMACEUTICALS INC (VNDA) · COMMUNITY HEALTH SYS INC NEW (CYH)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-23.